UCB (EBR:UCB) UCB Media Room: Disposals of own shares

Transparency directive : regulatory news

05/03/2021 20:03

https://mb.cision.com/Public/18595/3301175/b835cbfee2d98e99_800x800ar.jpg ** Disposals of own shares ------------------------------------------------------------ Brussels (Belgium), 5 March 2021 =E2=80=93 20:00 (CET) =E2=80=93 regulated = information In accordance with article 8:6 of the Royal Decree executing the Belgian Co= de of Companies and Associations, UCB SA/NV (=E2=80=9CUCB=E2=80=9D or the = =E2=80=9CCompany) (Euronext Brussels: UCB) announces that, following exerci= ses of stock options by members of its personnel, it has disposed of UCB sh= ares OTC in view of deliveries of these shares to the relevant members of t= he personnel, within the framework of the Long Term Incentive Program of th= e UCB Group, as follows: https://mb.cision.com/Public/18595/3301175/9d0d4e9b3f229171_800x800ar.png =C2=A0 In addition to these exercises, on 4 March 2021, under its Stock Award Plan= 2020, UCB SA/NV has delivered for free respectively 141 and 176 UCB shares= OTC to 2 members of the personnel of the Company and its subsidiaries. The highest independent bid price on Euronext Brussels on 4 March 2021 was = =E2=82=AC 81.06. This press release is available on UCB SA/NV=E2=80=99s website via the foll= owing link (https://www.ucb.com/stories-media/Press-Releases) . Investor Relations Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 Investor Relations, UCB T +32.2.559.94.14 antje.witte@ucb.com Isabelle Ghellynck, =C2=A0Investor Relations, UCB T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With approximately 8 400 peopl= e in approximately 40 countries, the company generated revenue of =E2=82=AC= 5.3 billion in 2020. UCB is listed on Euronext Brussels (symbol: UCB). Fol= low us on Twitter: @UCB_news GenericFile 210305 - Vervreemding van eigen aandelen (https://mb.cision.com/Public/1859= 5/3301175/b146cb2820a3825c.pdf) GenericFile 210305 - Ali=C3=A9nation d actions propres (https://mb.cision.com/Public/18= 595/3301175/ae50a84024885384.pdf) GenericFile 210305 - Disposals of own shares (https://mb.cision.com/Public/18595/330117= 5/a95b3edb5907666f.pdf) Image Chart 1 March 05 2021 (https://mb.cision.com/Public/18595/3301175/9d0d4e9b3= f229171_org.png)=0D =0D ______________________=0D If you would rather not receive future communications from UCB SA, please g= o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x63187x1x6868579x24000= x6&Email=3Dregnews%40symexglobal.com.=0D UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=

UCB's latest news

25/04/2024 18:00

UCB (EBR:UCB) UCB Media Room: Disposals of own shares

Transparency directive : regulatory news

UCB's latest news

Other stories